Cargando…
White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer
Liquid biopsies are providing new opportunities for detection of residual disease in cell-free DNA (cfDNA) after surgery but may be confounded through identification of alterations arising from clonal hematopoiesis. Here, we identify circulating tumor-derived DNA (ctDNA) alterations through ultrasen...
Autores principales: | Leal, Alessandro, van Grieken, Nicole C. T., Palsgrove, Doreen N., Phallen, Jillian, Medina, Jamie E., Hruban, Carolyn, Broeckaert, Mark A. M., Anagnostou, Valsamo, Adleff, Vilmos, Bruhm, Daniel C., Canzoniero, Jenna V., Fiksel, Jacob, Nordsmark, Marianne, Warmerdam, Fabienne A. R. M., Verheul, Henk M. W., van Spronsen, Dick Johan, Beerepoot, Laurens V., Geenen, Maud M., Portielje, Johanneke E. A., Jansen, Edwin P. M., van Sandick, Johanna, Meershoek-Klein Kranenbarg, Elma, van Laarhoven, Hanneke W. M., van der Peet, Donald L., van de Velde, Cornelis J. H., Verheij, Marcel, Fijneman, Remond, Scharpf, Robert B., Meijer, Gerrit A., Cats, Annemieke, Velculescu, Victor E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985115/ https://www.ncbi.nlm.nih.gov/pubmed/31988276 http://dx.doi.org/10.1038/s41467-020-14310-3 |
Ejemplares similares
-
Genome-wide cell-free DNA fragmentation in patients with cancer
por: Cristiano, Stephen, et al.
Publicado: (2019) -
Risk Factors for Metachronous Isolated Peritoneal Metastasis after Preoperative Chemotherapy and Potentially Curative Gastric Cancer Resection: Results from the CRITICS Trial
por: Caspers, Irene A., et al.
Publicado: (2021) -
Response to neoadjuvant chemotherapy and survival in molecular subtypes of resectable gastric cancer: a post hoc analysis of the D1/D2 and CRITICS trials
por: Biesma, Hedde D., et al.
Publicado: (2022) -
Venous thromboembolism during preoperative chemotherapy in the CRITICS gastric cancer trial
por: Slagter, Astrid E., et al.
Publicado: (2020) -
Triplet Chemotherapy with Cisplatin versus Oxaliplatin in the CRITICS Trial: Treatment Compliance, Toxicity, Outcomes and Quality of Life in Patients with Resectable Gastric Cancer
por: Slagter, Astrid E., et al.
Publicado: (2022)